Sanofi leans on COPD as 'next major growth pillar' for its immunology star Dupixent: CEO
Sanofi leans on COPD as 'next major growth pillar' for its immunology star Dupixent: CEO
fkansteiner
СМИ24.net — правдивые новости, непрерывно 24/7 на русском языке с ежеминутным обновлением *
